Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Stratification by interferon-γ release assay level predicts risk of incident TB.

Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM.

Thorax. 2018 Apr 5. pii: thoraxjnl-2017-211147. doi: 10.1136/thoraxjnl-2017-211147. [Epub ahead of print]

PMID:
29622693
2.

Bruk av antibiotika hos barn i perioden 2005 – 16.

Størdal K, Mårild K, Blix HS.

Tidsskr Nor Laegeforen. 2017 Oct 2;137(18). doi: 10.4045/tidsskr.17.0272. Print 2017 Oct 3. Norwegian.

3.

Antibiotic switch during treatment with antibiotics against respiratory tract infections in ambulatory care in Norway.

Blandhol M, Tysland T, Blix HS, Høye S.

Infect Dis (Lond). 2017 Nov - Dec;49(11-12):854-858. doi: 10.1080/23744235.2017.1350879. Epub 2017 Jul 25.

PMID:
28741975
4.

Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors.

Sverdrup Efjestad A, Ihle-Hansen H, Hjellvik V, Blix HS.

Dement Geriatr Cogn Dis Extra. 2017 Feb 9;7(1):30-40. doi: 10.1159/000454948. eCollection 2017 Jan-Apr.

5.

Antibiotikabruk og infeksjoner i sykehjem.

Alberg T, Holen Ø, Blix HS, Lindbæk M, Bentele H, Eriksen HM.

Tidsskr Nor Laegeforen. 2017 Mar 21;137(6):424. doi: 10.4045/tidsskr.17.0211. eCollection 2017 Mar. Norwegian. No abstract available.

PMID:
28332788
Free Article
6.

Broad-spectrum antibiotics in Norwegian hospitals.

Holen Ø, Alberg T, Blix HS, Smith I, Neteland MI, Eriksen HM.

Tidsskr Nor Laegeforen. 2017 Mar 7;137(5):362-366. doi: 10.4045/tidsskr.16.0622. eCollection 2017 Mar. English, Norwegian.

7.

Antibiotic use and infections in nursing homes.

Alberg T, Holen Ø, Blix HS, Lindbæk M, Bentele H, Eriksen HM.

Tidsskr Nor Laegeforen. 2017 Mar 7;137(5):357-361. doi: 10.4045/tidsskr.16.0621. eCollection 2017 Mar. English, Norwegian.

8.

An antibiotic's journey from marketing authorization to use, Norway.

Årdal C, Blix HS, Plahte J, Røttingen JA.

Bull World Health Organ. 2017 Mar 1;95(3):220-226. doi: 10.2471/BLT.16.172874. Epub 2017 Jan 19.

9.

Increased prescribing of systemic tetracyclines and isotretinoin for treatment of acne.

Odsbu I, Selmer R, Stålsby Lundborg C, Blix HS.

J Antimicrob Chemother. 2017 May 1;72(5):1510-1515. doi: 10.1093/jac/dkw586.

PMID:
28158436
10.

Antibiotic Use in Children - A Cross-National Analysis of 6 Countries.

Youngster I, Avorn J, Belleudi V, Cantarutti A, Díez-Domingo J, Kirchmayer U, Park BJ, Peiró S, Sanfélix-Gimeno G, Schröder H, Schüssel K, Shin JY, Shin SM, Simonsen GS, Blix HS, Tong A, Trifirò G, Ziv-Baran T, Kim SC.

J Pediatr. 2017 Mar;182:239-244.e1. doi: 10.1016/j.jpeds.2016.11.027. Epub 2016 Dec 21.

PMID:
28012694
11.

Antibiotic prescriptions and cycles of Mycoplasma pneumoniae infections in Norway: can a nationwide prescription register be used for surveillance?

Blix HS, Vestrheim DF, Hjellvik V, Skaare D, Christensen A, Steinbakk M.

Epidemiol Infect. 2015 Jul;143(9):1884-92. doi: 10.1017/S0950268814002908. Epub 2014 Nov 12.

12.

Use of antibiotics in nursing homes--surveillance with different methods.

Eriksen HM, Sæther AR, Viktil KK, Andberg L, Munkerud MW, Willoch K, Blix HS.

Tidsskr Nor Laegeforen. 2013 Oct 15;133(19):2052-6. doi: 10.4045/tidsskr.12.1480. English, Norwegian.

13.

How are drug regimen changes during hospitalisation handled after discharge: a cohort study.

Viktil KK, Blix HS, Eek AK, Davies MN, Moger TA, Reikvam A.

BMJ Open. 2012 Nov 19;2(6). pii: e001461. doi: 10.1136/bmjopen-2012-001461. Print 2012.

14.

[Patterns in the prescription of antihypertensive drugs in Norway, 1975-2010].

Blix HS, Landmark K, Selmer R, Reikvam A.

Tidsskr Nor Laegeforen. 2012 May 29;132(10):1224-8. doi: 10.4045/tidsskr.11.0984. Norwegian.

15.

[Increased use of antibiotics among nineteen-year-olds in May].

Blix HS, Hjellvik V.

Tidsskr Nor Laegeforen. 2012 May 15;132(9):1084-8. doi: 10.4045/tidsskr.11.1122. Norwegian.

16.

Review of the use of defined daily dose concept in drug utilisation research in China.

Teng L, Xin HW, Blix HS, Tsutani K.

Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1118-24. doi: 10.1002/pds.3240. Epub 2012 Mar 21. Review.

PMID:
22438276
17.

Choice of initial antihypertensive drugs and persistence of drug use--a 4-year follow-up of 78,453 incident users.

Selmer R, Blix HS, Landmark K, Reikvam A.

Eur J Clin Pharmacol. 2012 Oct;68(10):1435-42. doi: 10.1007/s00228-012-1261-2. Epub 2012 Mar 18.

PMID:
22427171
18.

Handling drug-related problems in rehabilitation patients: a randomized study.

Willoch K, Blix HS, Pedersen-Bjergaard AM, Eek AK, Reikvam A.

Int J Clin Pharm. 2012 Apr;34(2):382-8. doi: 10.1007/s11096-012-9623-5. Epub 2012 Mar 3.

PMID:
22388601
19.

Prevention of urinary tract infections in nursing homes: lack of evidence-based prescription?

Bergman J, Schjøtt J, Blix HS.

BMC Geriatr. 2011 Nov 1;11:69. doi: 10.1186/1471-2318-11-69.

20.

Cigarette smoking and risk of subsequent use of antibacterials: a follow-up of 365,117 men and women.

Blix HS, Hjellvik V, Litleskare I, Rønning M, Tverdal A.

J Antimicrob Chemother. 2011 Sep;66(9):2159-67. doi: 10.1093/jac/dkr273. Epub 2011 Jun 30.

PMID:
21719472
21.

European Surveillance of Antimicrobial Consumption (ESAC): systemic antiviral use in Europe.

Adriaenssens N, Coenen S, Kroes AC, Versporten A, Vankerckhoven V, Muller A, Blix HS, Goossens H; ESAC Project Group.

J Antimicrob Chemother. 2011 Aug;66(8):1897-905. doi: 10.1093/jac/dkr190. Epub 2011 May 27.

PMID:
21622674
22.

A multidisciplinary approach to improve drug therapy in nursing homes.

Davidsson M, Vibe OE, Ruths S, Blix HS.

J Multidiscip Healthc. 2011 Jan 11;4:9-13. doi: 10.2147/JMDH.S15773.

23.

How are antibacterials used in nursing homes? Results from a point-prevalence prescription study in 44 Norwegian nursing homes.

Blix HS, Bergman J, Schjøtt J.

Pharmacoepidemiol Drug Saf. 2010 Oct;19(10):1025-30. doi: 10.1002/pds.1980.

PMID:
20712026
24.

Evaluating categorisation and clinical relevance of drug-related problems in medication reviews.

Granas AG, Berg C, Hjellvik V, Haukereid C, Kronstad A, Blix HS, Kilhovd B, Viktil KK, Horn AM.

Pharm World Sci. 2010 Jun;32(3):394-403. doi: 10.1007/s11096-010-9385-x. Epub 2010 Apr 21.

PMID:
20407926
25.

Drugs with narrow therapeutic index as indicators in the risk management of hospitalised patients.

Blix HS, Viktil KK, Moger TA, Reikvam A.

Pharm Pract (Granada). 2010 Jan;8(1):50-5. Epub 2010 Mar 15.

26.

Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007-08.

Hauge SH, Blix HS, Borgen K, Hungnes O, Dudman SG, Aavitsland P.

Virol J. 2009 May 12;6:54. doi: 10.1186/1743-422X-6-54.

27.

[Antibiotic use in Norway].

Litleskare I, Blix HS, Rønning M.

Tidsskr Nor Laegeforen. 2008 Oct 23;128(20):2324-9. Norwegian.

28.

Risk of drug-related problems for various antibiotics in hospital: assessment by use of a novel method.

Blix HS, Viktil KK, Moger TA, Reikvam A.

Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):834-41. doi: 10.1002/pds.1595.

PMID:
18381745
29.

Identification of drug interactions in hospitals--computerized screening vs. bedside recording.

Blix HS, Viktil KK, Moger TA, Reikvam A.

J Clin Pharm Ther. 2008 Apr;33(2):131-9. doi: 10.1111/j.1365-2710.2007.00893.x.

PMID:
18315778
30.

The impact of clinical pharmacists on drug-related problems and clinical outcomes.

Viktil KK, Blix HS.

Basic Clin Pharmacol Toxicol. 2008 Mar;102(3):275-80. doi: 10.1111/j.1742-7843.2007.00206.x. Epub 2008 Jan 30. Review.

31.

[Classification of drug-related problems].

Ruths S, Viktil KK, Blix HS.

Tidsskr Nor Laegeforen. 2007 Nov 29;127(23):3073-6. Norwegian.

32.

Large variation in antibacterial use among Norwegian nursing homes.

Blix HS, Røed J, Sti MO.

Scand J Infect Dis. 2007;39(6-7):536-41.

PMID:
17577815
33.

Age- and gender-specific antibacterial prescribing in Norway.

Blix HS, Engeland A, Litleskare I, Rønning M.

J Antimicrob Chemother. 2007 May;59(5):971-6. Epub 2007 Feb 28.

PMID:
17329270
34.

Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams.

Blix HS, Viktil KK, Moger TA, Reikvam A.

Pharm World Sci. 2006 Jun;28(3):152-8. Epub 2006 Sep 27.

PMID:
17004023
35.

Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.

Viktil KK, Blix HS, Moger TA, Reikvam A.

Br J Clin Pharmacol. 2007 Feb;63(2):187-95. Epub 2006 Aug 30.

36.

Use of renal risk drugs in hospitalized patients with impaired renal function--an underestimated problem?

Blix HS, Viktil KK, Moger TA, Reikvam A.

Nephrol Dial Transplant. 2006 Nov;21(11):3164-71. Epub 2006 Jul 31.

PMID:
16880181
37.

Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs).

Viktil KK, Blix HS, Moger TA, Reikvam A.

Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):667-74.

PMID:
16598835
38.

Hospital usage of antibacterial agents in relation to size and type of hospital and geographical situation.

Blix HS, Hartug S.

Pharmacoepidemiol Drug Saf. 2005 Sep;14(9):647-9.

PMID:
15700320
39.

The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals.

Blix HS, Viktil KK, Reikvam A, Moger TA, Hjemaas BJ, Pretsch P, Vraalsen TF, Walseth EK.

Eur J Clin Pharmacol. 2004 Nov;60(9):651-8. Epub 2004 Oct 2.

PMID:
15568140
40.

Comparison of drug-related problems in different patient groups.

Viktil KK, Blix HS, Reikvam A, Moger TA, Hjemaas BJ, Walseth EK, Vraalsen TF, Pretsch P, Jorgensen F.

Ann Pharmacother. 2004 Jun;38(6):942-8. Epub 2004 Apr 6.

PMID:
15069168
41.

Problems in collecting comparable national drug use data in Europe: the example of antibacterials.

Rønning M, Blix HS, Strøm H, Skovlund E, Andersen M, Stichele RV.

Eur J Clin Pharmacol. 2003 Apr;58(12):843-9. Epub 2003 Mar 18.

PMID:
12698312
42.
43.

[Utilization of antibiotics in and outside of health facilities in Norway in 1998].

Blix HS.

Tidsskr Nor Laegeforen. 2000 Jun 10;120(15):1731-4. Norwegian.

Supplemental Content

Support Center